Form 4 for EOG EOG Resources
Accepted 2025-04-03 00:00:00 ET · period of report 2025-04-01 · accession 0001127602-25-011331 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-04-03 | 2025-04-01 | EOG | Leitzell Jeffrey R. | EVP, COO | D - Sale to Iss | $128.05 | -8,124 | 51.8K | -14% | -$1.04M |
| D | 2025-04-03 | 2025-04-01 | EOG | Leitzell Jeffrey R. | EVP, COO | M - OptEx | $127.00 | +8,190 | 59.9K | +16% | +$1.04M |
| DM | 2025-04-03 | 2025-04-01 | EOG | Leitzell Jeffrey R. | EVP, COO | S - Sale+OE | $127.76 | -4,037 | 51.7K | -7% | -$515.8K |
| D | 2025-04-03 | 2025-04-01 | EOG | Leitzell Jeffrey R. | EVP, COO | F - Tax | $128.05 | -29 | 51.8K | -0.1% | -$3,713 |
| D | 2025-04-03 | 2025-04-01 | EOG | Leitzell Jeffrey R. | EVP, COO | M - OptEx | $0.00 | -8,190 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-04-01 | D | D | 8,124 | $128.05 | 51,798.46 | D | — | — | |
| 2 | Common | Common Stock | 2025-04-01 | M | A | 8,190 | $127.00 | 59,922.46 | D | — | — | |
| 3 | Common | Common Stock | 2025-04-01 | S | D | 4,000 | $127.76 | 47,732.46 | D | — | — | |
| 4 | Common | Common Stock | 2025-04-01 | F | D | 29 | $128.05 | 51,769.46 | D | — | — | |
| 5 | Common | Common Stock | 2025-04-01 | S | D | 37 | $127.89 | 51,732.46 | D | — | — | |
| 6 | Derivative | Stock Appreciation Rights | 2025-04-01 | M | D | 8,190 | $0.00 | 0 | D | $127.00 · 2019-09-27 to 2025-09-27 | 8,190 Common Stock | (F1) The SARs granted became exercisable in increments of 33%, 33%, and 34% on each of the first three anniversaries, respectively, of the September 27, 2018 date of grant. The SARs granted became fully exercisable on September 27, 2021. |